牛逼牛逼_老虎社区_美港股上老虎 - 老虎社区

牛逼牛逼

一图看懂诺辉健康IPO

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":380992912,"tweetId":"380992912","gmtCreate":1612499802536,"gmtModify":1703762763169,"author":{"id":3472685385064684,"idStr":"3472685385064684","authorId":3472685385064684,"authorIdStr":"3472685385064684","name":"稳住不浪","avatar":"https://static.tigerbbs.com/ae6b82ebf641e4dd7a62664c43c4f876","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>牛逼牛逼</p></body></html>","htmlText":"<html><head></head><body><p>牛逼牛逼</p></body></html>","text":"牛逼牛逼","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/380992912","repostId":2109374058,"repostType":2,"repost":{"id":"2109374058","kind":"highlight","pubTimestamp":1612488126,"share":"https://www.laohu8.com/m/news/2109374058?lang=&edition=full","pubTime":"2021-02-05 09:22","market":"hk","language":"zh","title":"一图看懂诺辉健康IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2109374058","media":"格隆汇","summary":"发行区间为22.70港元-26.66港元，每手买卖单位500股，入场费约13464.33港元。","content":"<p>中国癌症早筛第一股诺辉健康(06606.HK)2021年2月5日-2月10日招股，预计2月18日上市。公司拟全球发售7659.8万股，其中香港发售766万股占10%，国际发售6893.8万股占90%，另有15%超额配股权；发行区间为22.70港元-26.66港元，每手买卖单位500股，入场费约13464.33港元；<a href=\"https://laohu8.com/S/GS\">高盛</a>和<a href=\"https://laohu8.com/S/UBS\">瑞银</a>为联合保荐人。</p><p>格隆汇APP获悉，诺辉健康是中国癌症筛查市场的先行者和领导者，公司旗下两款结直肠癌筛查产品已获国家药品监督管理局的批准并正式开始商业化，常卫清是中国首个且目前唯一一个获得国家药品监督管理局批准的癌症早筛产品。</p><p><img src=\"https://img3.gelonghui.com/cd98d-620fe251-b926-4755-87aa-ece508e2005a.png\" tg-width=\"706\" tg-height=\"10000\" referrerpolicy=\"no-referrer\"></p>","source":"gelonghui_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>一图看懂诺辉健康IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n一图看懂诺辉健康IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-05 09:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.gelonghui.com/p/445212><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中国癌症早筛第一股诺辉健康(06606.HK)2021年2月5日-2月10日招股，预计2月18日上市。公司拟全球发售7659.8万股，其中香港发售766万股占10%，国际发售6893.8万股占90%，另有15%超额配股权；发行区间为22.70港元-26.66港元，每手买卖单位500股，入场费约13464.33港元；高盛和瑞银为联合保荐人。格隆汇APP获悉，诺辉健康是中国癌症筛查市场的先行者和领导者...</p>\n\n<a href=\"http://www.gelonghui.com/p/445212\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img4.gelonghui.com/head/head126179_18906.png","relate_stocks":{"06606":"诺辉健康"},"source_url":"http://www.gelonghui.com/p/445212","is_english":false,"share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","article_id":"2109374058","content_text":"中国癌症早筛第一股诺辉健康(06606.HK)2021年2月5日-2月10日招股，预计2月18日上市。公司拟全球发售7659.8万股，其中香港发售766万股占10%，国际发售6893.8万股占90%，另有15%超额配股权；发行区间为22.70港元-26.66港元，每手买卖单位500股，入场费约13464.33港元；高盛和瑞银为联合保荐人。格隆汇APP获悉，诺辉健康是中国癌症筛查市场的先行者和领导者，公司旗下两款结直肠癌筛查产品已获国家药品监督管理局的批准并正式开始商业化，常卫清是中国首个且目前唯一一个获得国家药品监督管理局批准的癌症早筛产品。","news_type":1},"isVote":1,"tweetType":1,"viewCount":841,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/380992912"}